Evidence map›Paper›PMID 23707272›Full record

ArticlePain2013

Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure.

Andrey V Bortsov, Jennifer E Smith, Luda Diatchenko, April C Soward, Jacob C Ulirsch, Catherine Rossi, Robert A Swor, William E Hauda, David A Peak, Jeffrey S Jones and 8 more

Open access · greenAbstract read
In one paragraph

Article in Pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Review
  3. Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Observational
  6. The HPA Axis as Target for Depression.Current neuropharmacology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Frontiers in neuroscience · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Does epigenetic 'memory' of early-life stress predispose to chronic pain in later life? A potential role for the stress regulatorPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 2 countries.

Andrey V BortsovTRYUMPH Research Program, University of North Carolina, Chapel Hill, NC, USA.
Jennifer E Smith
Luda Diatchenko
April C Soward
Jacob C Ulirsch
Catherine Rossi
Robert A Swor
William E Hauda
David A Peak
Jeffrey S Jones
Debra Holbrook
Niels K Rathlev
Kelly A Foley
David C Lee
Renee Collette
Robert M Domeier
Phyllis L Hendry
Samuel A McLean
University of North Carolina at Chapel Hill · USSANE Mental Health Charity · GBBaystate Medical Center · USBeaumont Hospital, Royal Oak · USCone Health · USInova Fairfax Hospital · USMassachusetts General Hospital · USNorth Shore University Hospital · USSentara Norfolk General Hospital · USSpectrum Health · USTrinity Health Michigan · USUniversity of Florida · US

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
Genetic Predictors of Acute and Chronic Musculoskeletal Pain After Minor MVCR01AR056328 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MCLEAN, SAMUEL A. · 2008 to 2011
$2.9M
NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1RR025747NIAMS NIH HHS R01 AR056328
6 · The paper itself

Abstract

Individual vulnerability factors influencing the function of the hypothalamic-pituitary-adrenal axis may contribute to the risk of the development of persistent musculoskeletal pain after traumatic stress exposure. The objective of the study was to evaluate the association between polymorphisms in the gene encoding FK506 binding protein 51, FKBP5, a glucocorticoid receptor co-chaperone, and musculoskeletal pain severity 6 weeks after 2 common trauma exposures. The study included data from 2 prospective emergency department-based cohorts: a discovery cohort (n=949) of European Americans experiencing motor vehicle collision and a replication cohort of adult European American women experiencing sexual assault (n=53). DNA was collected from trauma survivors at the time of initial assessment. Overall pain and neck pain 6 weeks after trauma exposure were assessed using a 0-10 numeric rating scale. After adjustment for multiple comparisons, 6 FKBP5 polymorphisms showed significant association (minimum P<0.0001) with both overall and neck pain in the discovery cohort. The association of rs3800373, rs9380526, rs9394314, rs2817032, and rs2817040 with neck pain and/or overall pain 6 weeks after trauma was replicated in the sexual assault cohort, showing the same direction of the effect in each case. The results of this study indicate that genetic variants in FKBP5 influence the severity of musculoskeletal pain symptoms experienced during the weeks after motor vehicle collision and sexual assault. These results suggest that glucocorticoid pathways influence the development of persistent posttraumatic pain, and that such pathways may be a target of pharmacologic interventions aimed at improving recovery after trauma.

Indexed as

Accidents, TrafficAdolescentAdultAgedCohort StudiesDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMusculoskeletal PainPain MeasurementPolymorphism, Single NucleotideSex OffensesTacrolimus Binding Protein 5Tacrolimus Binding Proteins

Identifiers

PMID23707272
PMCPMC3699900
OpenAlexW1980718719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.